Human Serum Paraoxonase
Bharti Mackness, Paul N. Durrington, Mike Mackness · General Pharmacology The Vascular System · 1998
Cited by 350 works. doi:10.1016/s0306-3623(98)00028-7
Authors
References
- The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
- Serum esterases. 1. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination
- Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
- Serum esterases. 2. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E 600) and its identity with the A-esterase of mammalian sera
- Public health impact of pesticides used in agriculture
- The molecular basis of the human serum paraoxonase activity polymorphism
- Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
- Self-reported Illness and Health Status Among Gulf War Veterans A Population-Based Study
- Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
- Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.